Biomarkers for Prediction of Hand Function After Stroke - The ProHand Study (ProHand)

August 22, 2016 updated by: Danderyd Hospital

Recovery of Hand Function After Stroke- a Longitudinal Study Using Novel Methods to Quantify Hand Function and Connectivity in Brain Networks

The overall aim is to identify key determinants for recovery of hand function after stroke by applying newly developed hand function measures together with MRI measurements of the lesioned cerebral structures.

Study Overview

Status

Unknown

Conditions

Detailed Description

Almost half of surviving stroke patients are left with impaired function of the hand but individual profiles of weakness, spasticity, sensory and bimanual function vary widely. Improved prediction of recovery after stroke has broad implications for clinical decisions on the type, duration and goals of rehabilitation.

100 consecutive patients with 1st ever stroke and upper limb hemi-paresis will be subject to imaging, at 4 weeks and 6 months, and behavioral assessments at 4 weeks, 3 months and 6 months after stroke. The imaging protocol includes anatomical sequences for lesion mapping, diffusion tensor imaging and resting-state functional MRI for structural and functional connectivity analyses, respectively. Clinical hand function measures will be combined with novel validated methods to quantify spasticity,grip force control, sensory and bimanual function.

ProHand will provide insights into neural mechanisms related to recovery of hand function after stroke and enable enhanced prediction and development of targeted treatment trials.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Danderyd
      • Stockholm, Danderyd, Sweden, 18288
        • Recruiting
        • Danderyd University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients are recruited at entry to a specialized sub-acute rehabilitation unit after first time stroke

Description

Inclusion Criteria:

  • first ever stroke and clinically diagnosed arm paresis

Exclusion Criteria:

  • incapability to give informed concent and/or understand and comply with instructions, other disorders that may affect hand function (e.g. other neurological conditions, arthritis), cerebellar lesions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in Fugl-Meyer Assessment for Upper Extremity
Time Frame: From 4 weeks to 3 and six months
From 4 weeks to 3 and six months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Structural and functional connectivity measures; functional Magnetic Resonance Imaging
Time Frame: From 4 weeks to 6 months
From 4 weeks to 6 months
Change in NeuroFlexor(C) measures
Time Frame: From 4 weeks to 3 and 6 months
Quantitative measures of the neural and biomechanical components of the force resisting passive movement of ther wrist
From 4 weeks to 3 and 6 months
Change in modulation of gripforce: Visuomotor grip force tracking task
Time Frame: From 4 weeks to 3 and 6 months
From 4 weeks to 3 and 6 months
Change in Action Research Arm Test, ARAT
Time Frame: From 4 weeks to 3 and 6 months
From 4 weeks to 3 and 6 months
Change in Strength-Dexterity test
Time Frame: From 4 weeks to 3 and 6 months
Dexterous ability/quantification of precision in finger movements
From 4 weeks to 3 and 6 months
Change in grip force
Time Frame: From 4 weeks to 3 and 6 months
Dynamometry
From 4 weeks to 3 and 6 months
Change in Assisting Hand Assessment, AHA
Time Frame: From 4 weeks to 3 and 6 months
Measures of the spontaneous use of the more affected hand in specific bimanual activities
From 4 weeks to 3 and 6 months
Change in Box and Block Task, BBT
Time Frame: From 4 weeks to 3 and 6 months
From 4 weeks to 3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jörgen Borg, Professor, Department of Rehabilitation Medicine, Danderyd University Hospital, Karolinska Institutet

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (Anticipated)

December 1, 2017

Study Completion (Anticipated)

December 1, 2017

Study Registration Dates

First Submitted

August 22, 2016

First Submitted That Met QC Criteria

August 22, 2016

First Posted (Estimate)

August 25, 2016

Study Record Updates

Last Update Posted (Estimate)

August 25, 2016

Last Update Submitted That Met QC Criteria

August 22, 2016

Last Verified

August 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

3
Subscribe